Related Experiment Videos

Children with persistent cough--outcome with treatment and role of Moraxella catarrhalis?

P Gottfarb1, A Brauner

  • 1Department of Pediatrics, Sachsska Barnsjukhuset, Dalen Clinic, Enskededalen, Sweden.

Insights

Amoxycillin/clavulanic acid improved recovery in children with persistent cough. Moraxella catarrhalis was frequently found and may play a role in this condition.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Persistent cough in children is a common clinical problem.
  • The etiology of persistent cough is often multifactorial, including bacterial infections.
  • Moraxella catarrhalis is a common nasopharyngeal colonizer in children.

Purpose of the Study:

  • To investigate the efficacy of amoxycillin/clavulanic acid in treating severe persistent cough in children.
  • To identify the bacterial pathogens involved in persistent cough.
  • To explore the role of Moraxella catarrhalis in the pathogenesis of persistent cough.

Main Methods:

  • Prospective, double-blinded, randomized controlled study.
  • 52 children with severe persistent cough (>10 days) were enrolled.
  • Nasopharyngeal swabs were analyzed for bacterial colonization; patients received amoxycillin/clavulanic acid or placebo.

Main Results:

  • Moraxella catarrhalis was the predominant isolate (71%), followed by Haemophilus influenzae (30%) and Streptococcus pneumoniae (20%).
  • Laboratory-confirmed pertussis was present in 23% of children.
  • The antibiotic group showed significantly better recovery rates (p=0.02 pediatrician, p=0.002 parental assessment).

Conclusions:

  • Amoxycillin/clavulanic acid treatment is effective in managing severe persistent cough in children.
  • Moraxella catarrhalis is a potential causative agent in pediatric persistent cough.
  • Further research is warranted to elucidate the direct role of Moraxella catarrhalis in persistent cough pathogenesis.

Related Concept Videos